/ Print /

IN THE PIPELINE

Shingles vaccine wins approvalFDA approved the herpes zoster vaccine (Shingrix, GlaxoSmithKline) to treat shingles in adults aged 50 years and older.
ISMP issues insulin pen warning after patient deathMore education is needed for diabetic patients after a patient died from incorrectly using an insulin pen, according to a new warning from the Institute for Safe Medication Practices.
Drug shortages likely after hurricanesFDA Commissioner Scott Gottlieb, MD, said that the United States is likely to see shortages on certain drugs because after Hurricanes Irma and Maria knocked out power to the islands.
Aflibercept helps in ME patients with DR after cataract surgeryPatients with diabetic retinopathy have a high risk of developing macular edema after cataract surgery. Intravitreal injections of aflibercept might result in fewer patients developing macular edema in this patient population.
ALG-1001: Turning off the machinery of angiogenesisALG-1001 (Luminate, Allegro Ophthalmics) has a number of different mechanisms of action that benefit patients chronically treated with anti-vascular endothelial growth factor drugs and those who are treatment naïve.
AO imaging offers novel data for understanding retinal diseaseAdaptive optics (AO) is providing new insights about retinal structure and may help to identify potential areas for treatment of retinal diseases, said Mina Chung, MD.
FDA: Risk of blindness from compounded eye drugFDA warns that this compounded eye drug could lead to a disease that causes blindness.
Ophthalmology Times Bausch & Lomb Partner Perspective
First Zika test for blood donations wins nod from FDA
Novel device helps diabetics avoid stress linked to glucose testingFDA approved the first continuous glucose monitoring system that allows for diabetes treatment decisions without requiring a fingerstick.